Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy.

Bartalini L, Rimini M, Ikeda M, Abidoye O, Lucchetti J, Antonuzzo L, Kim JW, Vogel A, Lamarca A, Nichetti F, Saborowski A, Pressiani T, Vivaldi C, Rapposelli IG, Dekervel J, Braconi C, Pinato DJ, Tamburini E, Pircher CC, Tamberi S, Castet F, Verrico M, Parisi A, Couto N, Chon HJ, Martirena A, Landriscina M, Finkelmeier F, Oneda E, Avallone A, Dell'Aquila E, Perkhofer L, Kim IH, Formica V, de Sousa Pinto CM, Garajova I, Kang B, Corallo S, Fenocchio E, Farinea G, Pastorino A, Diana A, Yoo C, Schirripa M, Rodriquenz MG, Scartozzi M, Zumstein L, Ghidini M, Prager GW, Aprile G, Spinelli GP, Su YY, Chan SL, Warmington E, Lancianese A, Satake T, Bekaii-Saab T, Lavacchi D, Passeri L, Ferrara M, Kang M, Prete AA, Bozzarelli S, Persano M, Pretta A, Masi G, Balsano R, Niger M, Lonardi S, Salani F, Camera S, Fornaro L, Casadei-Gardini A, Rimassa L

Open source

DOI
10.3390/cancers18182921
Published
2026 Sep 9
Container
Cancers
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18182921,
  title = {Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy.},
  author = {Bartalini L and Rimini M and Ikeda M and Abidoye O and Lucchetti J and Antonuzzo L and Kim JW and Vogel A and Lamarca A and Nichetti F and Saborowski A and Pressiani T and Vivaldi C and Rapposelli IG and Dekervel J and Braconi C and Pinato DJ and Tamburini E and Pircher CC and Tamberi S and Castet F and Verrico M and Parisi A and Couto N and Chon HJ and Martirena A and Landriscina M and Finkelmeier F and Oneda E and Avallone A and Dell'Aquila E and Perkhofer L and Kim IH and Formica V and de Sousa Pinto CM and Garajova I and Kang B and Corallo S and Fenocchio E and Farinea G and Pastorino A and Diana A and Yoo C and Schirripa M and Rodriquenz MG and Scartozzi M and Zumstein L and Ghidini M and Prager GW and Aprile G and Spinelli GP and Su YY and Chan SL and Warmington E and Lancianese A and Satake T and Bekaii-Saab T and Lavacchi D and Passeri L and Ferrara M and Kang M and Prete AA and Bozzarelli S and Persano M and Pretta A and Masi G and Balsano R and Niger M and Lonardi S and Salani F and Camera S and Fornaro L and Casadei-Gardini A and Rimassa L},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18182921},
  url = {https://doi.org/10.3390/cancers18182921}
}

RIS

TY  - JOUR
TI  - Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy.
AU  - Bartalini L
AU  - Rimini M
AU  - Ikeda M
AU  - Abidoye O
AU  - Lucchetti J
AU  - Antonuzzo L
AU  - Kim JW
AU  - Vogel A
AU  - Lamarca A
AU  - Nichetti F
AU  - Saborowski A
AU  - Pressiani T
AU  - Vivaldi C
AU  - Rapposelli IG
AU  - Dekervel J
AU  - Braconi C
AU  - Pinato DJ
AU  - Tamburini E
AU  - Pircher CC
AU  - Tamberi S
AU  - Castet F
AU  - Verrico M
AU  - Parisi A
AU  - Couto N
AU  - Chon HJ
AU  - Martirena A
AU  - Landriscina M
AU  - Finkelmeier F
AU  - Oneda E
AU  - Avallone A
AU  - Dell'Aquila E
AU  - Perkhofer L
AU  - Kim IH
AU  - Formica V
AU  - de Sousa Pinto CM
AU  - Garajova I
AU  - Kang B
AU  - Corallo S
AU  - Fenocchio E
AU  - Farinea G
AU  - Pastorino A
AU  - Diana A
AU  - Yoo C
AU  - Schirripa M
AU  - Rodriquenz MG
AU  - Scartozzi M
AU  - Zumstein L
AU  - Ghidini M
AU  - Prager GW
AU  - Aprile G
AU  - Spinelli GP
AU  - Su YY
AU  - Chan SL
AU  - Warmington E
AU  - Lancianese A
AU  - Satake T
AU  - Bekaii-Saab T
AU  - Lavacchi D
AU  - Passeri L
AU  - Ferrara M
AU  - Kang M
AU  - Prete AA
AU  - Bozzarelli S
AU  - Persano M
AU  - Pretta A
AU  - Masi G
AU  - Balsano R
AU  - Niger M
AU  - Lonardi S
AU  - Salani F
AU  - Camera S
AU  - Fornaro L
AU  - Casadei-Gardini A
AU  - Rimassa L
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18182921
UR  - https://doi.org/10.3390/cancers18182921
ER  -

APA

L, B., M, R., M, I., O, A., J, L., L, A., JW, K., A, V., A, L., F, N., A, S., T, P., C, V., IG, R., J, D., C, B., DJ, P., E, T., CC, P., S, T., F, C., M, V., A, P., N, C., HJ, C., A, M., M, L., F, F., E, O., A, A., E, D., L, P., IH, K., V, F., CM, D. S. P., I, G., B, K., S, C., E, F., G, F., A, P., A, D., C, Y., M, S., MG, R., M, S., L, Z., M, G., GW, P., G, A., GP, S., YY, S., SL, C., E, W., A, L., T, S., T, B., D, L., L, P., M, F., M, K., AA, P., S, B., M, P., A, P., G, M., R, B., M, N., S, L., F, S., S, C., L, F., A, C., & L, R. (2026). Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy.. Cancers. https://doi.org/10.3390/cancers18182921

Source records